On June 17, Tianjin Pharma Da Ren Tang and Huawei Cloud Computing Technologies Co., Ltd. signed a comprehensive cooperation agreement at Huawei's headquarters in Shenzhen. Both parties will engage in deep collaboration across digital intellectualization transformation, process innovation, ecosystem alliances, and international markets to jointly advance the digital intellectualization upgrade of the traditional Chinese medicine industry.

Wang Lei, President of Tianjin Pharmaceuticals Group and Party Secretary and Chairman of Tianjin Pharma Da Ren Tang Group, along with Wang Bin, Head of Cloud-Native Enterprise Expansion for Huawei Cloud China, and Guo Feng, Head of Huawei Cloud Tianjin Business Department, led their respective teams attend the event.

Wang Lei stated that Da Ren Tang is founded on innovation. This partnership with Huawei Cloud represents a pivotal step for Da Ren Tang to drive comprehensive upgrades in R&D, supply chain, and services using digital intelligence as its engine. This collaboration is not only a combination of technologies but also a collision and innovation of concepts, marking a profound transformation centered on patient needs and focused on quality enhancement. He expressed anticipation that this collaboration will establish a comprehensive digital platform across Da Ren Tang's entire industrial chain, jointly create a new benchmark for smart traditional Chinese medicine and a new paradigm for TCM research and development, and collectively explore a "Cloud Ecosystem" for traditional Chinese medicine.

Wang Bin stated that this comprehensive deepening of cooperation marks a new chapter in the partnership between Huawei Cloud and Tianjin Pharma Da Ren Tang. Leveraging its technological strengths, Huawei Cloud will fully focus on implementing the Digital and Intelligent Da Ren Tang initiative. Through unified technical architecture, data integration, and process optimization, it will achieve intelligent upgrades across all business domains—research, production, supply, sales, and service—supporting Da Ren Tang's vision to become a market-driven, technology-empowered leader in the health industry. Moving forward, Huawei Cloud and Tianjin Pharma Da Ren Tang will collaborate more closely to establish best practices for digital and intelligent transformation in the traditional Chinese medicine sector, ushering in a new era of intelligent development for China's TCM industry.

 At the signing ceremony, Ye Hui, Chief Information Officer of Tianjin Pharma Da Ren Tang, and Guo Feng, Head of Huawei Cloud 's Tianjin Business Department, signed the cooperation agreement on behalf of both parties. President Wang Lei and Director Wang Bin witnessed the signing. The teams of both parties also engaged in in-depth discussions on areas such as integrated supply chain transformation and AI-driven empowerment across the entire industrial chain.

Huawei Cloud Computing Technologies Co., Ltd. is a globally leading provider of information and communications technology solutions. Leveraging robust R&D and comprehensive technical capabilities, it delivers comprehensive and efficient ICT solutions and services to enterprise clients across multiple domains including cloud computing, big data, smart park, data centers, networking, and industry applications.

Tianjin Pharma Da Ren Tang will leverage this collaboration as an opportunity to uphold the philosophy of preserving traditions without being bound by the past and innovating without straying from the essence. By harnessing Huawei Cloud’s "Black Soil" technology and advancing digital intelligence, it aims to revitalize traditional Chinese medicine with renewed vitality in the new era, jointly pioneering a promising future for its inheritance and innovative development.